Annovis Bio, Inc.ANVSNYSE
Loading
ROE: Returns DecliningContracting
Percentile Rank13
Studio
Year-over-Year Change

Return on equity

Percentile
P13
Within normal range
vs 2Y Ago
-0.2x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
2025-171.23%+35.2%
2024-264.20%-136.4%
2023725.13%+910.9%
2022-89.43%-174.7%
2021-32.56%+55.0%
2020-72.43%-726.8%
201911.55%+22.9%
20189.40%-4.0%
20179.79%-